While early outcomes have shown to be favorable, the limited follow-up highlights the need for longitudinal studies to clarify long-term recurrence rates, indications for secondary fusion, and comparative outcomes against traditional fusion techniques. UBE may enable precise FC removal with minimal tissue disruption, offering an alternative option for recurrent radiculopathy after ILP. This evidence concerns the gene XIAP and radiculopathy.